-
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
Equity healthcare
Overview ( as on 22/10/24 )
NAV
₹38.06
Last change
₹-0.64 -0.02%
Fund Size (AUM)
4987.49 Cr
Performance
31.28% (5Y)
Fund Details
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth
as of 22/10/24
AUM
4987.49 Cr
Expense Ratio
1.92 %
Benchmark
BSE Healthcare TR INR
ISIN
INF109KC1GE9
Fund Manager
Dharmesh Kakkad
Exit Load
1.0% if redeemed within 0-15 days
0% if redeemed after 15 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth | 58.39% | 22.73% | 31.28% |
| BSE Healthcare TR INR | 55.23% | 19.24% | 28.77% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
15.45% |
Dr Reddy's Laboratories Ltd |
9.63% |
Cipla Ltd |
6.52% |
Lupin Ltd |
4.64% |
Gland Pharma Ltd |
4.63% |
Aurobindo Pharma Ltd |
4.26% |
Apollo Hospitals Enterprise Ltd |
3.92% |
Divi's Laboratories Ltd |
2.86% |
HealthCare Global Enterprises Ltd |
2.55% |
Medplus Health Services Ltd |
2.3% |
Sector Allocation
Healthcare |
95.77% |
Financial |
2.48% |
Basic Materials |
1.76% |
Asset Allocation
-
95%
Equity
-
5%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
31.28% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
30.49% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
30.49% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
28.4% (5Y)
-
-
DSP Healthcare Fund Reg Gr
Equity healthcare-
Returns
-
32.23% (5Y)
-
-
Nippon India Pharma IDCW-P
Equity healthcare-
Returns
-
32.13% (5Y)
-
